Literature DB >> 15787096

Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling.

Ya-Min Fu1, Hui Zhang, Mingjie Ding, Yi-Qi Li, Xing Fu, Zu-Xi Yu, Gary G Meadows.   

Abstract

We had previously found that selective restriction of amino acids inhibits invasion of human A375 melanoma. Integrins, cell surface receptors for the components of extracellular matrix (ECM), are activated during cell adhesion and spreading, and initiate signaling pathways that control growth and invasion of tumor cells. We examined the effect of tyrosine (Tyr) and phenylalanine (Phe), methionine (Met) or glutamine (Gln) restriction on attachment and spreading of A375 and MeWo melanoma cell lines on fibronectin and laminin. In A375 cells, restriction of Tyr/Phe or Met inhibited attachment to and spreading on laminin and fibronectin, inhibited alpha3 and alpha4 integrin expression, and inhibited accumulation of FAK-Tyr397 and F-actin at leading edges of cell protrusions. Tyr/Phe restriction also inhibited attachment-induced autophosporylation of FAK-Tyr397. In MeWo cells, the order of inhibition by amino acid restriction on cell attachment and spreading was as follows: Gln > Tyr/Phe > Met. Restriction of Gln reduced alpha5 integrin expression. All amino acid restrictions similarly inhibited phosphorylation of FAK-Tyr397, FAK-Tyr577, FAK-Tyr861 and paxillin-Tyr31. Gln restriction exhibited the strongest inhibition of actin cytoskeleton remodeling during the cell spreading. The present study reveals that specific amino acid restriction inhibits attachment and spreading of melanoma via inhibition of specific integrin expression, inhibition of integrin-mediated FAK phosphorylation, and modulation of actin cytoskeleton remodeling. These data provide additional understanding of the mechanism by which specific amino acid restriction controls invasion and migration of melanoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15787096     DOI: 10.1007/s10585-004-5515-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations.

Authors:  Renhao Li; Neal Mitra; Holly Gratkowski; Gaston Vilaire; Rustem Litvinov; Chandrasekaran Nagasami; John W Weisel; James D Lear; William F DeGrado; Joel S Bennett
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

2.  Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation.

Authors:  Y Liu; E Kyle; R Lieberman; J Crowell; G Kellof; R C Bergan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction.

Authors:  C A Elstad; G G Meadows; R M Abdallah
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

4.  Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.

Authors:  P Laidler; D Gil; A Pituch-Noworolska; D Ciołczyk; D Ksiazek; M Przybyło; A Lityńska
Journal:  Acta Biochim Pol       Date:  2000       Impact factor: 2.149

5.  Alternatively spliced focal adhesion kinase in rat brain with increased autophosphorylation activity.

Authors:  F Burgaya; M Toutant; J M Studler; A Costa; M Le Bert; M Gelman; J A Girault
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

Review 6.  Cell adhesion molecules in the development and progression of malignant melanoma.

Authors:  J P Johnson
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

7.  Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.

Authors:  Y M Fu; Z X Yu; B A Pelayo; V J Ferrans; G G Meadows
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

8.  Alcohol consumption suppresses metastasis of B16-BL6 melanoma in mice.

Authors:  G G Meadows; C A Elstad; S E Blank; R M Gallucci; L J Pfister
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

9.  Rapid actin transport during cell protrusion.

Authors:  Daniel Zicha; Ian M Dobbie; Mark R Holt; James Monypenny; Daniel Y H Soong; Colin Gray; Graham A Dunn
Journal:  Science       Date:  2003-04-04       Impact factor: 47.728

10.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.

Authors:  X Zhu; M Ohtsubo; R M Böhmer; J M Roberts; R K Assoian
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  11 in total

Review 1.  The role of FAK in tumor metabolism and therapy.

Authors:  Jianliang Zhang; Steven N Hochwald
Journal:  Pharmacol Ther       Date:  2013-12-09       Impact factor: 12.310

2.  Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.

Authors:  Ya-Min Fu; Zu-Xi Yu; Huimin Lin; Xing Fu; Gary G Meadows
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

Review 3.  How does cancer cell metabolism affect tumor migration and invasion?

Authors:  Tianyu Han; De Kang; Daokun Ji; Xiaoyu Wang; Weihua Zhan; Minggui Fu; Hong-Bo Xin; Jian-Bin Wang
Journal:  Cell Adh Migr       Date:  2013-10-08       Impact factor: 3.405

Review 4.  Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.

Authors:  Melissa M Phillips; Michael T Sheaff; Peter W Szlosarek
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

5.  Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.

Authors:  Gaojie Liu; Jie Zhu; Menglei Yu; Canfeng Cai; Yu Zhou; Min Yu; Zhiqiang Fu; Yuanfeng Gong; Bin Yang; Yingru Li; Quanbo Zhou; Qin Lin; Huilin Ye; Liangtao Ye; Xiaohui Zhao; Zhihua Li; Rufu Chen; Fanghai Han; Chaoming Tang; Bing Zeng
Journal:  J Transl Med       Date:  2015-05-07       Impact factor: 5.531

6.  Tumour-suppressive function of SIRT4 in human colorectal cancer.

Authors:  M Miyo; H Yamamoto; M Konno; H Colvin; N Nishida; J Koseki; K Kawamoto; H Ogawa; A Hamabe; M Uemura; J Nishimura; T Hata; I Takemasa; T Mizushima; Y Doki; M Mori; H Ishii
Journal:  Br J Cancer       Date:  2015-06-18       Impact factor: 7.640

7.  Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.

Authors:  Lingqin Yuan; Xiugui Sheng; Adam K Willson; Dario R Roque; Jessica E Stine; Hui Guo; Hannah M Jones; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Endocr Relat Cancer       Date:  2015-06-04       Impact factor: 5.678

8.  Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.

Authors:  Kelly J Peyton; Xiao-Ming Liu; Yajie Yu; Benjamin Yates; Ghazaleh Behnammanesh; William Durante
Journal:  Biochem Pharmacol       Date:  2018-08-23       Impact factor: 5.858

9.  Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and Attachment.

Authors:  Yun Wang; Thomas M S Chang
Journal:  J Skin Cancer       Date:  2012-11-08

10.  JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.

Authors:  Juan Tan; Hao-Lian Wang; Jie Yang; Qian-Qian Liu; Chun-Min Li; Yun-Qian Wang; Lin-Na Fu; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.